PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Buprenorphine treatment in pregnancy and maternal-infant outcomes

JAMA Health Forum

2025-04-27
(Press-News.org) About The Study: In this cohort study of pregnant individuals with opioid use disorder, buprenorphine treatment was associated with improved outcomes for the mother and infant, underscoring the need to improve access to treatment nationwide.

Corresponding Author: To contact the corresponding author, Stephen W. Patrick, MD, MPH, MS, email stephen.patrick@emory.edu.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamahealthforum.2025.1814)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Media advisory: This study is being presented at the Pediatric Academic Societies 2025 meeting.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2025.1814?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=042725

About JAMA Health Forum: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

 

END


ELSE PRESS RELEASES FROM THIS DATE:

Donor lungs safely preserved up to 20 hours out-of-body prior to transplantation

2025-04-27
27 April 2025, Boston—A study on donor lungs preserved outside the body before transplantation demonstrated that the hypothermic oxygenated machine perfusion (HOPE) technique is a safe and effective lung preservation method, even with total out-of-body times approaching 20 hours.   Jitte Jennekens, MSc, organ perfusionist/transplant coordinator at the UMC Utrecht in the Netherlands, presented the study results at today’s Annual Meeting and Scientific Sessions of the International Society of Heart and Lung Transplantation (ISHLT) in Boston.   “This technique is being used to preserve donor livers and ...

Experts at ISHLT report urgent need for pediatric heart support devices

2025-04-27
Embargoed until 2:00 PM EST, Sunday, 27 April, 2025   EXPERTS AT ISHLT REPORT URGENT NEED FOR PEDIATRIC HEART SUPPORT DEVICES 27 April 2025, Boston—At today’s Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT) in Boston, Angela Lorts, MD, MBA, issued an urgent call for improved mechanical circulatory support (MCS) devices for children with life-threatening heart conditions. “Advances in pediatric cardiac disease are underfunded and understudied. Therapies are rarely developed for children. We modify adult therapies to use in pediatrics,” ...

DCD heart transplantation reaches 10-year mark, now up to 30% of transplant volumes

2025-04-27
27 April 2025, Boston—Researchers at the Annual Meeting and Scientific Sessions of the International Society of Heart and Lung Transplantation (ISHLT) marked the 10-year anniversary of modern heart donation after circulatory death (DCD), a technique that has significantly increased transplant volumes around the world. Sarah Scheuer, MD, PhD, said that most centers that have started a DCD program experience an approximately 30 percent increase in their transplant volume. “It’s arguably the biggest shift in heart transplantation ...

Immunotherapy before and after surgery improves outcomes in head and neck cancer

2025-04-27
Immunotherapy before and after surgery improves outcomes in head and neck cancer   Dana-Farber Brigham Cancer Center-led phase 3 clinical trial shows that pembrolizumab before and after standard-of-care surgery significantly extends event-free survival, representing the first advance for these patients in over 20 years BOSTON, April 27, 2025 — Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival without the cancer coming back and higher rates of substantial tumor shrinkage prior to surgery, according to the first interim ...

Donor hearts are traveling longer distances with machine perfusion

2025-04-27
Embargoed until 10:30 AM EST, Sunday, 27 April, 2025   DONOR HEARTS ARE TRAVELING LONGER DISTANCES WITH MACHINE PERFUSION Technology Could Pave the Way to International Heart Exchange  27 April 2025, Boston—In places like Australia, where metropolitan areas are separated by an entire continent, donor hearts used to go unused simply because transplant teams couldn’t get the organ to a recipient in time. “If there isn’t a recipient for an available heart in Perth but there’s a match in Sydney, that's nearly 2,000 miles of travel, or a five-hour flight,” said Emily Granger, MBBS, cardiothoracic and heart and lung transplant ...

Six leading organizations unite to launch the pediatric heart transplant alliance

2025-04-27
Six Leading Organizations Unite to Launch the Pediatric Heart Transplant Alliance Chicago, Illinois – 27 April, 2025 – A groundbreaking collaboration among leading organizations in pediatric heart transplantation has led to the formation of Pediatric Heart Transplant Alliance. Founding partners include Enduring Hearts, the International Society for Heart and Lung Transplantation (ISHLT), Pediatric Heart Transplant Society (PHTS), Transplant Families, Advanced Cardiac Therapies Improving Outcomes Network (ACTION), and Additional Ventures. The mission of the Alliance is to serve as a powerful coalition spotlighting the need for advancements in pediatric heart transplantation ...

Effect of coupled wing motion on the aerodynamic performance during different flight stages of pigeon

2025-04-27
A research paper by scientists at Beijing Institute of Technology presented a CFD simulation method based on biological experimental data to analyze the aerodynamic performance of pigeons during takeoff, leveling flight, and landing in free flight. The research paper, published on Mar. 11, 2025 in the journal Cyborg and Bionic Systems. Birds achieve remarkable maneuverability in takeoff, steady flight, and landing by continuously and adaptively morphing their wing shape, yet existing bio-inspired flapping-wing ...

Cercus electric stimulation enables cockroach with trajectory control and spatial cognition training

2025-04-26
A research paper by scientists at Beijing Institute of Technology presented a steering control strategy for cyborg insects in operant learning training of cockroaches in a T-maze. Cockroaches developed a preference for specific maze channels after only five consecutive sessions of unilateral cercus electrical stimulation and steering behavior induction, achieving a memory score of 83.5%, outperforming traditional punishing training schemes. The research paper, published on Mar. 7, 2025 in the journal Cyborg and Bionic Systems. Cyborg insects are highly adaptable for detection and recognition assignments, achieved through the electrical stimulation of multiple organs ...

Day-long conference addresses difficult to diagnose lung disease

2025-04-26
26 April 2025, Boston—Chronic thromboembolic pulmonary hypertension (CTEPH) often goes undiagnosed for years, is frequently caught late, and primarily affects young, otherwise healthy individuals. Even when diagnosed, finding the right treatment can be challenging.   At this year’s Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT), a day-long CTEPH conference—co-sponsored by ISHLT and the International CTEPH Association (ICA) —brought together ...

First-ever cardiogenic shock academy features simulation lab

2025-04-26
26 April 2025, Boston—Healthcare practitioners from around the world received hands-on training for treating patients in cardiogenic shock (CS) during a first-ever simulation lab at today’s Annual Meeting and Scientific Sessions of the International Society of Heart and Lung Transplantation (ISHLT) in Boston. The simulation lab was part of ISHLT’s inaugural Cardiogenic Shock Academy, a day-long session featuring a case-based forum and discussion of hot topics and anticipated developments ...

LAST 30 PRESS RELEASES:

Can exercise and rehab services be integrated into breast cancer care?

Simple test could better predict your risk of heart disease

Global study links consumption of ultraprocessed foods to preventable premature deaths

Accurate and rapid arthritis diagnosis in just 10 minutes

Hospital-based outbreak detection system saves lives

AACR: Topical treatment offers relief from painful skin rash caused by targeted cancer therapy

Buprenorphine treatment in pregnancy and maternal-infant outcomes

Donor lungs safely preserved up to 20 hours out-of-body prior to transplantation

Experts at ISHLT report urgent need for pediatric heart support devices

DCD heart transplantation reaches 10-year mark, now up to 30% of transplant volumes

Immunotherapy before and after surgery improves outcomes in head and neck cancer

Donor hearts are traveling longer distances with machine perfusion

Six leading organizations unite to launch the pediatric heart transplant alliance

Effect of coupled wing motion on the aerodynamic performance during different flight stages of pigeon

Cercus electric stimulation enables cockroach with trajectory control and spatial cognition training

Day-long conference addresses difficult to diagnose lung disease

First-ever cardiogenic shock academy features simulation lab

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

[Press-News.org] Buprenorphine treatment in pregnancy and maternal-infant outcomes
JAMA Health Forum